Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Taprenepag | 752187-80-7 | 98.8% | 478.52 | 50 MG
SDP

Supplier:  Medchemexpress LLC HY1489950MG

Encompass_Preferred

Taprenepag (CP-544326) is a potent and selective prostaglandin EP(2) agonist with IC50s of 10 and 15 nM for human and rat EP2, respectively. It demonstrates selectivity for EP2 over other EP receptors (IC50s > 3200 nM for EP1, EP3, and EP4) and a panel of 37 G protein-coupled receptors. It increases cAMP levels in HEK293 cells expressing human EP2 (EC50=2.8 nM) and has poor corneal permeability in an ex vivo rabbit corneal model.

  • Potent and selective prostaglandin EP(2) agonist
  • Shows selectivity for EP2 over other EP receptors
  • Increases cAMP levels in HEK293 cells
  • Has poor corneal permeability in an ex vivo rabbit corneal model

Catalog No. 50-003-61160


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.